Cerebrotendinous xanthomatosis, a metabolic disease with different neurological signs: two case reports
暂无分享,去创建一个
G. Corso | A. Dello Russo | S. Savastano | M. Gentile | G. Fortunato | M. D. Di Taranto | C. Giacobbe | G. Marotta | Monica Gelzo
[1] M. D'Agostino,et al. Functional characterization of mutant genes associated with autosomal dominant familial hypercholesterolemia: integration and evolution of genetic diagnosis. , 2015, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[2] Xuebing Cao,et al. Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management , 2014, Orphanet Journal of Rare Diseases.
[3] L. del Vecchio,et al. The novel variant p.Ser465Leu in the PCSK9 gene does not account for the decreased LDLR activity in members of a FH family , 2014, Clinical chemistry and laboratory medicine.
[4] F. Blanco-Vaca,et al. Sitosterolemia: Diagnosis, Investigation, and Management , 2014, Current Atherosclerosis Reports.
[5] A. Federico,et al. A suspicion index for early diagnosis and treatment of cerebrotendinous xanthomatosis , 2014, Journal of Inherited Metabolic Disease.
[6] G. Corso,et al. Sterol profiles in plasma and erythrocyte membranes in patients with Smith-Lemli-Opitz syndrome: a six-year experience , 2011, Clinical chemistry and laboratory medicine.
[7] L. del Vecchio,et al. An improved method on stimulated T-lymphocytes to functionally characterize novel and known LDLR mutations[S] , 2011, Journal of Lipid Research.
[8] S. Rossi,et al. Clinical relevance and neurophysiological correlates of spasticity in cerebrotendinous xanthomatosis , 2011, Journal of Neurology.
[9] G. Corso,et al. Plasma levels of conjugated bile acids in newborns after a short period of parenteral nutrition. , 2010, JPEN. Journal of parenteral and enteral nutrition.
[10] M. D. de Barse,et al. Elevated cholesterol precursors other than cholestanol can also be a hallmark for CTX , 2008, Journal of Inherited Metabolic Disease.
[11] S. Panico,et al. Small dense LDL particles and metabolic syndrome in a sample of middle-aged women. Findings from Progetto Atena. , 2008, Clinica chimica acta; international journal of clinical chemistry.
[12] D. Campion,et al. Unusual cerebrotendinous xanthomatosis with fronto‐temporal dementia phenotype , 2005, American journal of medical genetics. Part A.
[13] M. A. Croce,et al. Four novel mutations of sterol 27-hydroxylase gene in Italian patients with cerebrotendinous xanthomatosis. , 1997, Journal of lipid research.
[14] U. Francke,et al. Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis. , 1991, The Journal of biological chemistry.
[15] G. Tint,et al. Biosynthesis of bile acids in cerebrotendinous xanthomatosis. Relationship of bile acid pool sizes and synthesis rates to hydroxylations at C-12, C-25, and C-26. , 1985, The Journal of clinical investigation.
[16] A. Batta,et al. Effect of chenodeoxycholic acid on biliary and urinary bile acids and bile alcohols in cerebrotendinous xanthomatosis; monitoring by high performance liquid chromatography. , 1985, Journal of lipid research.